The biopharmaceutical company Rockwell Medical is anxiously awaiting approval from the FDA for its injectable Vitamin D drug, Calcitriol CAS# 32222-06-3. This promising new indication approval was submitted in April of 2013, with the goal of better managing hypocalcemia in patients who experience chronic renal dialysis. As an active injectable treatment known as the brand[…]
Calcitriol Poised for FDA Approval as Vitamin D to Treat Hypocalcemia
Hormonal Agent, Hypocalcemia, Patent Expiration 2019 Tags: hypocalcemia Feb 10, 2014
Vitamin D Analogues Clinically Useful for Several Conditions
Anti-Psoriatic, Chemotherapeutic / Anti-Neoplastic, Drug Research & Development API, Hypocalcemia, Osteoporosis Tags: hypocalcemiaosteoporosisplaque psoriasisPsoriasisvitamin D May 02, 2012
Calcium regulation in the human body. The role of vitamin D is shown in orange. There are several active pharmaceutical ingredient products known as vitamin D analogues, which are derivatives of this powerful vitamin, designed to aid patients’ health and well being. Vitamin D is known by many people as the vitamin that helps to[…]